Renal Flashcards
What is cystatin C?
• Endogenous cysteine proteinase inhibitor that is produced at a constant rate by all nucleated cells and released into plasma
• 99% filtered by glomeruli
• NO tubular secretion or reabsorption into plasma
• After filtration it is completely absorbed into proximal tubular cells and catabolised
• Usually none found in urine
• Therefore
o Plasma cystatin C is a good marker of GFR
o Urine cystatin C might be a good marker of tubular injury
• Evidence: in a systemic review
o Serum cystatin C 84% sensitive for AKI, 82% specific, AUC 0.96
o Performed better than Cr in estimating GFR in some circumstances (e.g. low muscle mass)
What is NGAL (neutrophil gelatinase associated lipocalin)?
• Originally found bound to gelatinase from human neutrophils
• Possibly a bacteriostatic protein that scavenges bacterial iron containing proteins, other possible roles
• Expression upregulated following ischaemia in renal proximal epithelial cells, possibly to ameliorate oxidatve stress
o Increased NGAL in urine is from renal tubular cells
• Urine NGAL found to
o Predict development of AKI in critically ill patients (i.e. gives early diagnosis of AKI)
o Predict sustained AKI
• Meta-analysis showed (in critically ill patients)
o Diagnostic odds ratio = 10
o AUC = 0.73
Other than fluids, what has been shown to reduce risk of contrast-induced AKI?
- IV hydration = most important intervention to reduce risk of CI-AKI in at-risk patients
- Low contrast volume
- Non-ionic contrast (low or iso-osmolar)
- NAC - heterogeneous results; KDIGO does recommend using oral NAC + IV N Saline in patients at increased risk
- Statins - several RCTs support protective effects of statins (possibly through effects on inflammation/endothelium)
Risk of rhabdomyolysis is usually low when CK is less than…
CK <15,000 to 20,000
List some drugs that cause acute tubular necrosis
Aminoglycosides Vancomycin Amphotericin Contrast Cisplatin Cyslosporin, tacrolimus Foscarnet
What is the most common cause of acute tubulointerstitial nephritis (RACP 2018 AKI lecture)?
Proton pump inhibitors
What is the definition of AKI using the KDIGO criteria?
AKI is defined as any of the following
• Increase in serum Cr >=0.3 mg/dL (>=26.5 umol/L) within 48 hours
• Increase in serum Cr to >=1.5x baseline, which is known or presumed to have occurred within prior 7 days
• Urine volume <0.5 mL/kg/hour for 6 hours
Staging
Stage 1. Serum Cr 1.5-1.9x baseline OR >=26.5 umol/L increase, OR urine output <0.5mL/kg/h for 6-12 hours
Stage 2. Serum Cr 2-2.9x baseline OR UO <0.5mL/kg/h for >=12h
Stage 3. Serum Cr 3x baseline OR increase by >=353.6 umol/L OR initiation of RRT OR eGFR <35 in patients aged <18. OR UO <0.3mL/kg/h for >=24h OR anuria for >=12h